Previous studies have shown that NASP promotes the proliferation of various human cancer cells, including hepatocellular carcinoma, prostate cancer, melanoma, and gastric cancer, and can be used as a marker of poor prognosis.17, 34, 35, 36. Here, NASP is linked to prostate carcinoma.